Microbial fermentation provides a powerful manufacturing platform for recombinant proteins and other biotechnology products. The major development challenge is to translate biological performance observed at laboratory scale into a reproducible commercial process. Important parameters include host selection, clone/strain development, media optimization, oxygen transfer, feeding strategy, temperature and pH, biomass development, product expression, harvest, purification and process consistency.
A scalable fermentation program generally progresses through strain development → shake-flask studies → bench-scale fermentation → pilot scale → engineering batches → GMP production. Shilpa Biologicals describes microbial capabilities involving Pichia and E. coli, while its published CDMO material identifies microbial development and scale-up from laboratory through larger manufacturing scales.
Modern fermentation development increasingly focuses on higher cell density, improved volumetric productivity, optimized feeding, reduced cycle times, better downstream recovery and consistent product quality. Shilpa Biologicals' published scientific work describes process development for recombinant proteins using Pichia pastoris, including optimization of upstream productivity and downstream purity.
Commercial fermentation is not simply a matter of increasing vessel size. Successful scale-up requires understanding the biological and engineering behavior of the process at each scale and building appropriate controls around the critical process parameters.
